Skip to main content
Charles Lusch, MD, Oncology, Reading, PA

CharlesJLuschMD

Oncology Reading, PA

Consultant, Kimmel Cancer Center at Jefferson

Dr. Lusch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lusch's full profile

Already have an account?

Education & Training

  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalFellowship, Hematology and Medical Oncology, 1967 - 1968
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1965 - 1967
  • Tower Health
    Tower HealthResidency, Internal Medicine, 1962 - 1965
  • Tower Health
    Tower HealthInternship, Transitional Year, 1961 - 1962
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 1961
  • Lafayette College
    Lafayette CollegeA.B., Magna Cum Laude, 1953 - 1957

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1962 - 2024
  • HI State Medical License
    HI State Medical License 2003 - 2020
  • SC State Medical License
    SC State Medical License 1988 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Recognition Best Doctors, 1996-2014
  • Senate Award for service to patients of central Pennsylvania Pennsylvania Senate, 2008
  • First "Healthcare Champion" Berks County VNA, 2008
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Phase II Pilot Study of Daly Oral Etoposide and Hexamethylmelamine (Altretamine) In Small Cell Carcinoma of the Lung  
    Langer C.; Sprandio J.; Lusch, C.; Rousch R.; Kosierowski R.; Ozols R.; Fox S.; Reilly R.; Sarker C.R.; Galligher C., American Society of Clinical Oncology, 1/1/1999
  • A Phase II Confirmatory Study of Antitumor Efficacy and Safety of Exemestane (EXE) As Third-Line Hormonal Treatment of Postmenopausal Patients (PTS) With Metastatic Br...  
    Jones S.; Chang A.; Lusch C.; Belt R.; Arkhipov A.; Royer M.; Polli A.; di Salle E.; Miller L., Proceedings of the San Antonio Breast Cancer Conference, 1/1/1998
  • Radionuclide Resting Left Ventricular Ejection Fraction (LVEF/MUGA Measurements in Breast Cancer Patients Receiving Adriamycin Based Chemotherapy for Advanced Disease  
    D.V. Spicer; Lusch, C.J., Proceedings from the 1992 American Society of Clinical Oncology, 1/1/1992
  • Join now to see all

Professional Memberships